Table 4 Discounted and undiscounted incremental lifetime total medical costs of ERT versus no ERT treatment, overall and by gender
From: Cost-effectiveness of enzyme replacement therapy for Fabry disease
Discount rate 4% | Discount rate 0% | |||||
|---|---|---|---|---|---|---|
ERT | No ERT | Difference | ERT | No ERT | Difference | |
ALL | €2,504,727 | €83,772 | €2,420,956 | €9,918.352 | €270,964 | €9.647,388 |
MALES | €2,433,824 | €85,305 | €2,348,519 | €9,615,920 | €272,892 | €9,343,028 |
FEMALES | €2,516,273 | €81,624 | €2,434,649 | €10,056,623 | €267,517 | €9,789,106 |